Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Alignment Healthcare, Inc. Director's Dealing 2021

Nov 25, 2021

31270_dirs_2021-11-24_e189ab67-e656-4ded-bb72-5856ca97369f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Alignment Healthcare, Inc. (ALHC)
CIK: 0001832466
Period of Report: 2021-11-23

Reporting Person: GENERAL ATLANTIC, L.P. (Director, 10% Owner)
Reporting Person: GENERAL ATLANTIC GENPAR, L.P. (Director, 10% Owner)
Reporting Person: General Atlantic Partners 95, L.P. (Director, 10% Owner)
Reporting Person: GAP COINVESTMENTS III, LLC (Director, 10% Owner)
Reporting Person: GAP COINVESTMENTS IV, LLC (Director, 10% Owner)
Reporting Person: GAP Coinvestments V, LLC (Director, 10% Owner)
Reporting Person: GAPCO GMBH & CO KG (Director, 10% Owner)
Reporting Person: GAPCO MANAGEMENT GMBH (Director, 10% Owner)
Reporting Person: GAP Coinvestments CDA, L.P. (Director, 10% Owner)
Reporting Person: General Atlantic (SPV) GP, LLC (Director, 10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-11-23 Common Stock, par value $0.001 per share S 6259298 $20.1075 Disposed 70069317 Indirect

Footnotes

F1: The shares of Common Stock were sold by General Atlantic (ALN HLTH), L.P., a Delaware limited partnership ("GA ALN"), pursuant to a registered public offering that closed on November 23, 2021 (the "Transaction"), at a price of $20.1075 (net of underwriting discount).

F2: Reflects securities held directly by GA ALN following the closing of the Transaction. The limited partners of GA ALN are the following investment funds (the "GA Funds"): General Atlantic Partners 95, L.P., a Delaware limited partnership ("GAP 95"), GAP Coinvestments CDA, L.P., a Delaware limited partnership ("GAPCO CDA"), GAP Coinvestments III, LLC, a Delaware limited liability company ("GAPCO III"), GAP Coinvestments IV, LLC, a Delaware limited liability company ("GAPCO IV"), GAP Coinvestments V, LLC, a Delaware limited liability company ("GAPCO V") and GAPCO GmbH & Co. KG, a German partnership ("GAPCO KG"). (Cont'd in FN3)

F3: (Cont'd from FN2) General Atlantic GenPar, L.P., a Delaware limited partnership ("GA GenPar"), is the general partner of GAP 95. General Atlantic (SPV) GP, LLC, a Delaware limited liability company ("GA SPV"), is the general partner of GA ALN. General Atlantic, L.P., a Delaware limited partnership ("GA LP") is the general partner of GA GenPar and GAPCO CDA, the managing member of GAPCO III, GAPCO IV and GAPCO V, and the sole member of GA SPV. GA LP is controlled by the Management Committee of GASC MGP, LLC (the "Management Committee"). GAPCO Management GmbH, a German company ("GAPCO Management"), is the general partner of GAPCO KG. There are nine members of the Management Committee. Each of the members of the GA Management Committee disclaims ownership of the shares except to the extent he has a pecuniary interest therein.